Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.819
https://www.valueinhealthjournal.com/article/S1098-3015(13)00890-5/fulltext
Section Title :
Diabetes/Endocrine Disorders
Section Order :
367
First Page :
A164
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00890-5&doi=10.1016/j.jval.2013.03.819